US Patent Issued to HK inno.N on Oct. 6 for "Crystalline form of heterocyclic compound as protein kinase inhibitor" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,174, issued on Oct. 6, was assigned to HK inno.N Corp. (Chungcheongbuk-do, South Korea).

"Crystalline form of heterocyclic compound as protein kinase inhibitor" was invented by Young Ju Kim (Seoul, South Korea), Jun Kim (Seoul, South Korea), Hanna Kim (Seoul, South Korea), Jae Hong Kweon (Seoul, South Korea), Ye-Lim Lee (Seoul, South Korea) and Do Seok Hwang (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a crystalline form of the heterocyclic compound N-(4-(1-(2-cyanoacetyl)-3-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-6-yl)cyclopropanecarboxamide as a protein kinase inhibitor....